MENACTRA
Google image searchProduct monograph
Active ingredients
meningococcal polysaccharide-diphtheria toxoid conjugate, group a, 4.0 MCG/0.5 ML
meningococcal polysaccharide-diphtheria toxoid conjugate, group c, 4.0 MCG/0.5 ML
meningococcal polysaccharide-diphtheria toxoid conjugate, group y, 4.0 MCG/0.5 ML
meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135, 4.0 MCG/0.5 ML
DIN: 02279924
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 20-OCT-2006
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AH — Meningococcal vaccines (ATC, ATC/DDD)
- J07AH08 — MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED (ATC/DDD)
Reference brand drug: Menactra, Menveo
External Links for Menactra
Search on Google
- Menactra side effects
- Menactra dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group c side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group c dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group y side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group y dosage
- meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 side effects
- meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 dosage
